Molecular Devices, LLC supplies high-performance analytical systems, including instruments, software, and reagents, to accelerate and improve drug discovery and basic life science research. By providing systems that address just about any combination of throughput, content, and budget needs, Molecular Devices helps pharmaceutical and biotechnology as well as academic and government labs leverage advances in molecular, cellular, and systems science to understand normal and abnormal biological functions and discover and develop novel therapeutics and tests.
Molecular Devices® products are based on proprietary core technologies that integrate expertise in engineering and biological sciences. The company has long history of developing innovative, first-to-market products that have enabled its customers to improve laboratory productivity and effectiveness.
Molecular Devices is based in Silicon Valley, CA, United States, and has regional offices in the United Kingdom, Germany, Austria, Brazil, Korea, China, and Japan to support the global life sciences—drug discovery and basic research—communities.
New hires at Molecular Devices
-
President
Came from...
Thermo Fisher Scientific, President, Chromatography & Mass Spectrometry Division
-
Vice President Drug Discovery
Came from...
Leica Microsystems, Business Development Director
-
Supply Chain Director
Came from...
ASTEELFLASH Group, Lean Manufacturing Manager for US & China Region
-
-
Sr. Technical Sales Representative - BioResearch
Came from...
Luminex Corporation, Life Science Research Business Manager
Molecular Devices Activity on LinkedIn
-
-
-
-
-
Molecular Devices has a new Field Application Scientist
Jeff Clubs is now Field Application Scientist
-
Molecular Devices Webinar Alert: High Throughput Assessment of Cardiomyocytes using the FLIPR® Tetra System and the NEW ScreenWorks® Peak Pro™ Software -- Wednesday, January 18, 2012 / 8am PST
-
Molecular Devices Don't miss this chance to network with fellow scientists and Molecular Devices experts for a morning of interactive discussions and presentations on novel applications for drug discovery including assays performed with the FLIPR® Tetra System and IonWorks™ Barracuda System. The workshop will be hosted in conjunction with the First Annual SLAS2012 Conference & Exhibition, as part of the Sunday morning workshop schedule. Continental breakfast will be served. (February 5, 2012 / 9am-noon)
